329249-47-0 Usage
Uses
Used in Pharmaceutical Industry:
N-Methyl-N-[2-(4-nitrophenoxy)ethyl]-2-pyridinamine is used as a building block for the development of new drugs. Its unique structure and functional groups make it a promising candidate for the synthesis of pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, N-Methyl-N-[2-(4-nitrophenoxy)ethyl]-2-pyridinamine is used as a precursor for the development of new pesticides. Its chemical properties can be utilized to create effective and targeted pest control agents.
Used in Research and Development:
N-Methyl-N-[2-(4-nitrophenoxy)ethyl]-2-pyridinamine is used as a research compound for the synthesis of other organic compounds. Its versatile structure allows for further modification and exploration of its potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 329249-47-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,9,2,4 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 329249-47:
(8*3)+(7*2)+(6*9)+(5*2)+(4*4)+(3*9)+(2*4)+(1*7)=160
160 % 10 = 0
So 329249-47-0 is a valid CAS Registry Number.
329249-47-0Relevant academic research and scientific papers
Benzamide compounds as apo b secretion inhibitors
-
, (2008/06/13)
The present invention relates to compounds of the formula (I) wherein R1 and R2 are each independently lower alkyl lower alkenyl, acyl, amino, lower alkoxy, lower cycloalkyloxy, aryl, aryloxy, sulfooxy, mercapto, sulfo, hydrogen, halogen, nitro, cyano or hydroxy, or may form a ring structure; Q1 is N or CH; L is optionally substituted unsaturated 3 to 10-membered heterocyclic group; X is optionally substituted monocyclic arylene or monocyclic heteroarylene; Y is -(A1)m-(A2)n-(A4)k-; Z is directbond, —CH2-, —NH— or —O—; and R is hydrogen or lower alkyl, or a salt thereof The compounds of the present invention inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.
